If you are looking for a good critical analysis of what is available for treating cancer then you need to read my two cancer books – see www.fightingcancer.com for more information
Vitamin C – Countering Propaganda
The following press release speaks for itself:
FOR IMMEDIATE RELEASE
Orthomolecular Medicine News Service, September 15, 2010
Cancer and Vitamin C:
(OMNS September 15, 2010) The very first paper in the Puerto Rico Health
Sciences Journal’s special issue on cancer condemns vitamin C therapy for
cancer. (1) Furthermore, that Journal has refused publication of a letter
correcting the article’s numerous errors. We have therefore decided to provide
OMNS readers with that rebuttal letter, below:
It is entirely false to assert that we do not know how much vitamin C is
effective against cancer. Indeed, the opposite is true: we do know, and we
are failing our duty to patients when we fail to recommend vitamin C as
adjunctive cancer therapy.
There are many controlled studies that demonstrate that vitamin C is
indeed effective against cancer, improving length of life and quality of life.
Positive studies have typically used between 10,000 and 100,000 mg/day
intravenously. As Dr. Fernando Cabanillas correctly noted, success with 10,000
mg/day by IV was initially reported back in the 1970s by Cameron and
Pauling. But Dr. Cabanillas has then omitted some key information. It is
to note that the negative, much-touted Moertel-Mayo studies were not true
replications of Cameron and Pauling’s work, as A) they used oral doses
only, and B) vitamin C was discontinued at the first sign of disease
progression. Would we administer injectable chemotherapy orally, and then
chemotherapy if the patient worsened? No, we would administer it properly,
and stay with it.
Dr. Cabanillas also neglects to mention that Pauling and Cameron’s work
was promptly confirmed, first at Japan’s Saga University by Murata et al. Dr.
Murata employed over 30,000 mg per day and had even better results with
terminally ill cancer patients. (2) In the words of Dr. Louis Lasagna of the
University of Rochester Medical School, “It seems indefensible not to at
least try substantial doses of vitamin C in these patients.” (3)
And again contrary to Dr. Cabanillas’ statements, many clinical reports
from orthomolecular (nutritional) physicians including Dr. Hugh Riordan and
colleagues do in fact indicate that IV vitamin C is effective. Says Dr.
James A. Jackson, “Dr. Riordan’s IV protocol (4) starts out at 15,000 mg
intravenous ascorbate and slowly goes up. It is given twice a week. The IVs are
continued until the post-IV vitamin C levels reach what our research
established as the killing level of 350 to 400 mg/dL. This has been verified.
Once this level is reached, the frequency of the IV may be reduced to once a
week, or to one or two times a month.”
There is no absolutely reliable cure for cancer. Conventional chemotherapy
contributes only 2.1% to five year cancer survival in the USA. (6) But
with vitamin C, we are on the right track. It has been reported since
McCormick in the 1950s (7,8,9) that cancer patients invariably have abnormally
levels of the vitamin. Vitamin C is vital to a cancer patient. What is
dangerous is vitamin deficiency. What is even more dangerous is warning people
off the very therapy that may help them, and frequently has been shown to
make a significant difference.
Precisely how significant remains to be seen. But there are intriguing
indications. Linus Pauling took 18,000 mg/day of vitamin C. Pauling died from
cancer in 1994. Dr. Charles Moertel of the Mayo Clinic, critic of vitamin
C, died of cancer the same year. Moertel was 66. Pauling was 93. Did vitamin
C fail to cure Pauling’s cancer? If so, then not taking vitamin C failed
to cure Moertel’s. Pauling lived 27 years longer with ascorbate than Moertel
lived without it.
Andrew W. Saul
(end of letter)
Vitamin C does not interfere with conventional cancer treatment
Victor Marcial, M.D., an oncologist in Puerto Rico, says:
**We studied patients with advanced cancer (stage 4). 40 patients received
40,000-75,000 mg intravenously several times a week. These are patients
that have not responded to other treatments. The initial tumor response rate
was achieved in 75% of patients, defined as a 50% reduction or more in
tumor size. . . As a radiation oncologist, I also give radiation therapy.
Vitamin C has two effects. It increases the beneficial effects of radiation and
chemotherapy and decreases the adverse effects. But this is not a subtle
effect, is not 15-20%. It’s a dramatic effect. Once you start using IV
vitamin C, the effect is so dramatic that it is difficult to go back to not
Ralph Campbell, M.D., a Montana pediatrician, writes:
**More and more oncologists are admitting that a course of chemo disrupts
the immune system to the point of allowing more cancer down the pike. It
would seem reasonable for post-chemo patients to enter a regimen of high
antioxidants intake as soon as they can.**
More and more medical doctors support adjunctive vitamin C therapy for
cancer. The PRHSJ needs to publish both sides of the story. If you would like
encourage them to do so, you may write directly to:
For more information about vitamin C cancer therapy:
You can watch an excerpt from the movie FOODMATTERS discussing vitamin C
therapy for cancer at
La medicina ortomolecular en español:
1)Presentan primera guía ortomolecular para el manejo del cáncer:
(1) PRHSJ, Vol 29, No 3, Sept, 2010. Read the paper, or the entire issue,
(http://prhsj.rcm.upr.edu/index.php/prhsj/issue/current/showToc) The direct
download link for the paper in question is
(2) Murata, A., Morishige, F. and Yamaguchi, H. (1982) Prolongation of
survival times of terminal cancer patients by administration of large doses of
ascorbate. International Journal of Vitamin and Nutrition Research Suppl.,
23, 1982, p. 103-113. Also in Hanck, A., ed. (1982) Vitamin C: New
Clinical Applications. Bern: Huber, 103-113.
(5) Padayatty SJ, Sun H, Wang Y, Riordan HD, Hewitt SM, Katz A, Wesley RA,
Levine M. Vitamin C pharmacokinetics: implications for oral and
intravenous use. Ann Intern Med. 2004 Apr 6;140(7):533-7. Free full-text article
(http://www.annals.org/content/140/7/533.long) or as a pdf download at
See also: Padayatty SJ, Riordan HD, Hewitt SM, Katz A, Hoffer LJ, and
Levine M. Intravenously administered vitamin C as cancer therapy: three cases.
CMAJ. 2006 March 28; 174(7): 937-942. Free full-text article at
(6) Morgan G, Ward R, Barton M. The contribution of cytotoxic chemotherapy
to 5-year survival in adult malignancies. Clin Oncol (R Coll Radiol). 2004
(7) McCormick WJ. Cancer: the preconditioning factor in pathogenesis; a
new etiologic approach. Arch Pediatr. 1954 Oct;71(10):313-22. Also: McCormick
WJ. [Cancer: predisposition as pathogenesis; new data on its etiology.]
Union Med Can. 1955 Mar;84(3):272-7. French.
(8) McCormick WJ. Cancer: a collagen disease, secondary to a nutritional
deficiency. Arch Pediatr. 1959 Apr;76(4):166-71. Also: McCormick WJ. [Is
cancer a collagen disease attributable to vitamin C deficiency.] Union Med
Can. 1959 Jun;88(6):700-4. French.
(9) McCormick WJ. Have we forgotten the lesson of scurvy? J Applied
Nutrition, 1962, 15(1,2) p 4-12.
Nutritional Medicine is Orthomolecular Medicine
The peer-reviewed Orthomolecular Medicine News Service is a non-profit and
non-commercial informational resource.
Editorial Review Board:
Ralph K. Campbell, M.D. (USA)
Carolyn Dean, M.D., N.D. (Canada)
Damien Downing, M.D. (United Kingdom)
Michael Ellis, M.D. (Australia)
Michael Gonzalez, D.Sc., Ph.D. (Puerto Rico)
Steve Hickey, Ph.D. (United Kingdom)
Bo H. Jonsson, M.D., Ph.D. (Sweden)
Thomas Levy, M.D., J.D. (USA)
Jorge R. Miranda-Massari, Pharm.D. (Puerto Rico)
Erik Paterson, M.D. (Canada)
Gert E. Shuitemaker, Ph.D. (Netherlands)
This article may be reprinted free of charge provided 1) that there is
clear attribution to the Orthomolecular Medicine News Service, and 2) that
both the OMNS free subscription link
and also the OMNS archive link
ources/omns/index.shtml) are included.